Bloomin' Brands, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Bloomin' Brands, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	4,261	4,223	4,126	4,139	3,171	4,122	4,009	4,168	3,950	3,956
Cost of revenue	1,355	1,317	1,296	1,278	983	1,230	1,237	1,240	1,148	1,177
Gross profit	2,906	2,906	2,831	2,862	2,188	2,893	2,772	2,928	2,803	2,779
General and administrative	268	307	283	275	254	246	213	234	219	238
Operating income	124	139	145	191	-175	309	306	283	140	37.2
Other non-operating income	1.61	14.9	-0.01	-0.14	0.13	0.03	-0.02
Pre-tax income	52.6	111	100	142	-240	249	127	231	-58.8	-8.19
Income tax	8.65	7.53	-9.23	7.57	-80.7	26.4	34.3	18.4	-12.1	-26.7
Income from continuing operations							85.9	206	-52	8.77
Net income to minority interests	4.6	2.32	2.44	3.54	-0.08	7.36	7.3	7.03	5.36	4.99
Net income	39.4	101	107	131	-159	216	102	247	-128	8.24
EBITDA	318	331	347	388	5.29	472	456	452	315	215
EPS, basic			1.16	1.47	-1.85	2.42	1.15	2.84	-1.49	0.10
EPS, diluted			1.14	1.45	-1.85	2.00	1.03	2.56	-1.49	0.10
Shares, basic (weighted)				88.8	87.5	89	88.8	87.2	85.9	85.1
Shares, diluted (weighted)	114	99.7	94.1	89.8	87.5	108	98.5	96.5	85.9	85.3
Dividend per share	0.28	0.32	0.36	0.40	0.20	0.00	0.56	0.96	0.96	0.45

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	127	128	71.8	67.1	110	87.6	84.7	112	70.1	59.5
Inventory	65.2	51.3	72.8	86.9	61.9	79.1	78.1	62.9	68.7	61.5
Other current assets	190	179	191	186	152	185	184	138	159	149
Total current assets	391	360	335	340	324	353	347	343	321	270
Property, plant and equipment	1,237	1,173	1,116	1,036	888	842	914	928	949	913
Lease right-of-use assets			0	1,267	1,173	1,131	1,103	1,031	1,013	979
Goodwill	310	310	295	288	271	268	273	213	213	185
Intangible assets	536	522	504	471	460	453	448	433	429	425
Other non-current assets	129	135	121	117	92.6	78.7	82.1	60.1	74.5	111
Total assets	2,642	2,562	2,465	3,593	3,362	3,294	3,320	3,424	3,385	3,172
Accounts payable	195	185	174	175	141	168	184	156	153	138
Accrued liabilities	82	114	101	101	79.3	105	84.1	71.8	64.5	79.4
Deferred revenue	389	331	343	369	382	399	394	380	374	378
Short-term debt	35.1	26.3	27.2	26.4	38.7	11	1.64
Total current liabilities	823	813	791	962	950	985	979	1,002	952	879
Long-term debt	1,054	1,092	1,068			782	832
Lease liabilities			0	1,279	1,218	1,179	1,149	1,087	1,089	1,046
Other non-current liabilities	219	210	192	138	185	125	90.5	83	93.4	113
Total liabilities	2,446	2,481	2,410	3,415	3,351	3,071	3,047	3,012	3,245	2,835
Total debt	1,089	1,118	1,068	1,022	998	782	829	781	1,027	787
Paid-in capital	1,080	1,082	1,108	1,094	1,133	1,120	1,162	1,115	1,273	1,241
Retained earnings	-787	-913	-920	-755	-918	-698	-706	-529	-926	-918
Other comprehensive income	-111	-99.2	-143	-170	-211	-206	-185	-178	-213	9.11
Shareholders' equity	183	70.3	45.7	170	4.15	216	271	409	136	334
Minority interests	12.7	10.9	9.09	7.14	6.81	6.39	2.54	2.88	3.94	3.56
Total equity	226	81.2	54.8	177	11	223	274	412	139	337
Total liabilities and equity	2,642	2,562	2,465	3,593	3,362	3,294	3,320	3,424	3,385	3,172
Shares outstanding	104	91.9	91.3	86.9	87.9	89.3	87.7	87	84.9	85.2

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	44	104	110	134	-159	223	109	254	-123	13.2
Depreciation and amortization	194	192	202	197	180	163	150	169	176	178
Stock-based compensation	21.5	25.9	27.4	24.7	14.8	24.4	16.3	11.7	7.48	7.78
Deferred income tax	-76.8	-28.1	-29.5	-25.9	-88.3	-3.35	11.5	-8.41	-30.3	-38.2
Change in inventory	15.1	11.1	-24.7	-15.4	19.9	-18.2	1.82	2.8	-7.48	6.44
Cash from operations	341	409	288	318	139	402	391	532	228	277
Capital expenditures	-261	-261	-208	-162	-87.8	-123	-193	-282	-221	-180
Acquisitions	0
Cash from investing	295	-123	-177	-131	-76.6	-105	-201	-317	-239	2.11
Debt issued				0	0	200	0	0
Debt repaid	-356	-75.5	-26.7	-27.3	-26.3	-431
Share buybacks	-310	-273	-114	-107	0	0	-109	-70.8	-266	0
Dividends paid	-31.4	-31	-33.3	-35.7	-17.5	0	-49.7	-83.7	-82.6	-38.3
Cash from financing	-658	-294	-164	-189	-16.8	-317	-196	-187	-23.5	-289
Exchange rate effect	2.96	0.98	-4.15	-1.63	-2.17	-1.64
Net change in cash	-19.2	-6.64	-57.7	-4.68	43.3	-21.4	-4.32	29.6	-44.3	-10.6
Free cash flow	80	148	79.9	156	51	280	198	250	7.4	96.8
Interest paid	41.6	40.5	41.7	47.9	52.6	47	39.1	50.9	60	58.6
Income taxes paid	88.8	33.4	15.8	24	8.42	36.3	35.5	27.8	21.1	41.1

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 28, 2026; growth uses fiscal years. Valuation uses the share price of $7.88 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	70.1%	Gross profit / revenue.
Operating margin	1.2%	Operating income / revenue.
EBITDA margin	5.8%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	0.0%	Pre-tax income / revenue.
Net margin	0.7%	Net income / revenue.
FCF margin	3.9%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	8.0%	Cash from operations / revenue.
Effective tax rate	-5,712.0%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	6.4%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	0.9%	Net income / average total assets.
Return on invested capital (ROIC)	3.5%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	0.3%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	4.1%	Capital expenditures / revenue.
D&A / revenue	4.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	0.1%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-0.4%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	4.5%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-0.9%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	0.1%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	4.9%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-73.4%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-50.5%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y	-31.9%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-22.2%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	109.8%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income CAGR, 3y	-56.8%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 3y	-54.0%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	21.3%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-10.9%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	14.8%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	1,209.0%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-21.2%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	13.7%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	-53.1%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	-7.0%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	17.6%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	146.2%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	7.1%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	140.5%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-6.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-1.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-1.2%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.7%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-4.7%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.5%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.25x	Current assets / current liabilities.
Quick ratio	0.08x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.08x	(Cash + short-term investments) / current liabilities.
Debt / equity	1.63x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	22.5%	Total debt / total assets.
Liabilities / assets	86.0%	Total liabilities / total assets.
Net debt	$636.2M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	2.78x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	-$614.4M	Current assets - current liabilities.
Goodwill and intangibles / assets	19.5%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$176.7M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.28x	Revenue / average total assets.
Fixed asset turnover	4.43x	Revenue / average property, plant and equipment.
Inventory turnover	19.7x	Cost of revenue / average inventory.
Days inventory	19 days	365 x average inventory / cost of revenue.
Days payables	47 days	365 x average accounts payable / cost of revenue.
FCF conversion	560.2%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	51.5%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.32	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$46.15	Revenue / diluted weighted shares.
FCF per share	$1.80	Free cash flow / diluted weighted shares.
Operating cash flow per share	$3.71	Cash from operations / diluted weighted shares.
Book value per share	$5.04	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$2.06	Tangible book value / shares outstanding.
Cash per share	$0.78	(Cash + short-term investments) / shares outstanding.
Payout ratio	46.1%	Dividends paid / net income, when net income is positive.
Dividends / FCF	8.2%	Dividends paid / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$674.3M	Share price x shares outstanding.
Enterprise value	$1.31B	Market cap + total debt - cash - short-term investments.
P/E	24.4x	Market cap / net income. Only when net income is positive.
P/S	0.17x	Market cap / revenue.
P/B	1.56x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	4.35x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	2.11x	Market cap / cash from operations, when positive.
EV/Sales	0.33x	Enterprise value / revenue.
EV/EBIT	27.5x	Enterprise value / operating income, when both are positive.
EV/EBITDA	5.72x	Enterprise value / EBITDA, when both are positive.
EV/FCF	8.46x	Enterprise value / free cash flow, when both are positive.
FCF yield	23.0%	Free cash flow / market cap.
Earnings yield	4.1%	Net income / market cap (the inverse of P/E).
Dividend yield	1.9%	Dividends paid over the period / market cap.
Shareholder yield	1.9%	(Dividends paid + share buybacks) / market cap.

What was Bloomin' Brands, Inc.'s revenue in fiscal 2025?

Bloomin' Brands, Inc. reported revenue of $3.96B for fiscal 2025, 0.1% higher than the year before.

Was Bloomin' Brands, Inc. profitable in fiscal 2025?

Yes. Net income was $8.2M, a net margin of 0.2%.

How much free cash flow did Bloomin' Brands, Inc. generate in fiscal 2025?

Cash from operations of $276.7M minus capital expenditures of $179.9M left free cash flow of $96.8M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Bloomin' Brands, Inc.